Univ of Iowa Hospitals & Clinics, Genetics
Univ of Iowa Hospitals & Clinics, Genetics is a company.
Active
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at Univ of Iowa Hospitals & Clinics, Genetics.
Univ of Iowa Hospitals & Clinics, Genetics is a company.
Key people at Univ of Iowa Hospitals & Clinics, Genetics.
The University of Iowa Hospitals & Clinics (UIHC) Genetics division, primarily through the Division of Medical Genetics and Genomics and the Iowa Institute of Human Genetics (IIHG), is an academic medical unit focused on diagnosing, treating, and researching genetic disorders rather than a commercial company.[1][2] It provides comprehensive clinical services for children, adults, and prenatal patients, including general genetics clinics, metabolic genetics, connective tissue disorder clinics, neurofibromatosis clinics, cancer predisposition, and multidisciplinary tuberous sclerosis clinics, supported by a team of board-certified geneticists, genetic counselors, nurse practitioners, and dietitians.[1][4][6] The division excels in advanced testing via the Shivanand R. Patil Cytogenetics and Molecular Laboratory (CAP-inspected, CLIA-certified) for chromosome analysis, FISH, microarrays, and genome sequencing, alongside education for healthcare providers and research into rare disorders like inherited bone marrow failure and monogenic diseases.[1][2]
Its research arm, IIHG, supports cutting-edge projects in cancer, cystic fibrosis, muscular dystrophy, and personalized genomic medicine through lab testing, bioinformatics, and interdisciplinary collaboration across UIowa departments.[2][4] Specialized offerings include KidneySeq (330+ genes for 120+ renal diseases), APOL1 genotyping, and rare kidney disease clinics, positioning it as a national reference for molecular diagnostics and genetic counseling.[4]
The Division of Medical Genetics and Genomics within UIowa's Department of Pediatrics has evolved as part of the university's longstanding commitment to genetics, housing key facilities like the Shivanand R. Patil Cytogenetics and Molecular Laboratory, which uses state-of-the-art methods for genetic analysis.[1] The IIHG integrates genetics across disciplines, fostering a "Genetics Cluster Initiative" for collaborative personalized medicine, with roots in supporting UIowa's research from basic sciences to clinical care.[2] UIHC's genetics services expanded through affiliations like UI Diagnostic Laboratories (UIDL) for molecular genetic testing and renal biopsies, alongside regional outreach via Iowa's Regional Genetic Consultation Service (RGCS) to ensure statewide access.[4][9]
Training programs mark pivotal growth: a two-year Medical Genetics and Genomics Residency (ACGME-accredited) to train clinical geneticists, a combined Pediatrics & Medical Genetics four-year fast-track residency, and a Laboratory Genetics and Genomics Fellowship for cytogenetic/molecular expertise.[3][5][7][8] These programs build on UIowa's academic tradition, preparing professionals for STEM careers including genetic counseling and molecular genetics.[2]
UIHC Genetics rides the wave of personalized genomic medicine, leveraging genome sequencing, bioinformatics, and AI-driven analyses to address rare diseases affecting fewer than 200,000 Americans, such as the 150+ rare kidney disorders.[1][2][4] Timing aligns with surging demand for precision diagnostics post-genomic era advancements like CRISPR and multi-omics, amplified by market forces including expanded genetic testing coverage, rising hereditary cancer awareness, and tele-genetics outreach amid clinician shortages.[6] It influences the ecosystem by training the next generation of geneticists/counselors, supporting UIowa's interdisciplinary clusters (bioethics, law, communications), and providing reference lab services that accelerate research translation into healthcare, particularly in underserved rural states like Iowa.[2][9]
UIHC Genetics will expand influence through scaling molecular diagnostics (e.g., more gene panels like KidneySeq) and AI-enhanced variant interpretation, fueled by trends in polygenic risk scores and equitable access via RGCS outreach.[4][9] Expect deeper integration with national trials and pharma partnerships for rare disease therapies, evolving its role from regional hub to global leader in translational genomics. This positions it to shape Iowa's biotech ecosystem, bridging academia and patient care in an era of routine whole-genome sequencing.[1][2]
Key people at Univ of Iowa Hospitals & Clinics, Genetics.
